CXCR2 deficient mice display macrophage-dependent exaggerated acute inflammatory responses by Dyer, Douglas P. et al.
1Scientific RepoRts | 7:42681 | DOI: 10.1038/srep42681
www.nature.com/scientificreports
CXCR2 deficient mice display 
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Gerard J. Graham
CXCR2 is an essential regulator of neutrophil recruitment to inflamed and damaged sites and plays 
prominent roles in inflammatory pathologies and cancer. It has therefore been highlighted as an 
important therapeutic target. However the success of the therapeutic targeting of CXCR2 is threatened 
by our relative lack of knowledge of its precise in vivo mode of action. Here we demonstrate that CXCR2-
deficient mice display a counterintuitive transient exaggerated inflammatory response to cutaneous 
and peritoneal inflammatory stimuli. In both situations, this is associated with reduced expression of 
cytokines associated with the resolution of the inflammatory response and an increase in macrophage 
accumulation at inflamed sites. Analysis using neutrophil depletion strategies indicates that this is a 
consequence of impaired recruitment of a non-neutrophilic CXCR2 positive leukocyte population. We 
suggest that these cells may be myeloid derived suppressor cells. Our data therefore reveal novel and 
previously unanticipated roles for CXCR2 in the orchestration of the inflammatory response.
The chemokine family is comprised of approximately 45 structurally related proteins that, along with their cog-
nate G-protein coupled receptors (GPCRs) expressed on circulating cells1, mediate the in vivo migration and 
recruitment of leukocytes2,3. Broadly speaking chemokines, and their receptors, can be defined as being either 
inflammatory or homeostatic according to the contexts in which they function4,5. Inflammatory chemokines play 
specific roles in choreographing leukocyte migration in response to inflammatory or infectious stimuli, however 
the precise functional roles played by individual chemokines and their receptors in this complex process remain 
poorly defined. Not surprisingly, inflammatory chemokines and their receptors are essential contributors to a 
range of immune and inflammatory pathologies. They also play fundamental roles in tumourigenesis6–9. Overall 
therefore, the inflammatory chemokine/receptor system represents an important therapeutic target although 
attempts at developing therapeutically useful antagonists of chemokine receptor have so far met with extremely 
limited success10,11. There are many potential reasons for this one of which is our, currently, poorly developed 
understanding of the complexity of the inflammatory chemokine/receptor system and its role in regulating 
inflammation. We contend that a clearer understanding of this system is required before chemokine receptor 
antagonists can be used effectively as therapeutic agents.
Despite the general lack of success, one promising target currently being pursued is the neutrophil-expressed 
chemokine receptor CXCR2 which, alongside its ligands CXCL1–3 and CXCL5–8, regulates neutrophil recruit-
ment in a number of pathological contexts12,13. Thus it is a viable therapeutic target in, for example, COPD and 
other neutrophilic inflammatory pathologies. In addition, recent experimental evidence has highlighted an 
important role for CXCR2 in cancer formation and maintenance8. Specifically, targeting of CXCR2 has resulted 
in suppression of inflammatory skin and intestinal tumorogenesis14, reduced spontaneous adenocarcinoma for-
mation in the intestine14, decreased acute myeloid leukemia15, inflammatory bowel disease16, nasopharyngeal car-
cionoma17 and rhabdomyosarcoma (in combination with anti-PD1)18. Accordingly, small molecule antagonists of 
CXCR2 are being actively tested for potential anti-cancer effects in vivo.
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In this study we looked, in detail, at the impact of CXCR2 deletion on the kinetics of the inflammatory 
response. We now report a counterintuitive transient exaggeration of inflammatory response in CXCR2-deficient 
mice in models of both skin and peritoneal inflammation. This phenotype was associated with increased accumu-
lation of macrophages at inflamed sites in CXCR2-deficient mice and was dependent on CXCR2-driven recruit-
ment of a suppressor cell population to the acutely inflamed environment. We hypothesise that these cells may be 
myeloid derived suppressor cells. In summary, our study reveals a novel role for CXCR2 in limiting the magnitude 
of the macrophage-dependent inflammatory response.
Results
CXCR2-deficient mice display excessive cutaneous inflammatory responses. We initially 
hypothesised that CXCR2-deficient mice would demonstrate a reduced inflammatory response to the phorbol 
ester TPA due to the key role that CXCR2 plays in neutrophil migration. To test this we measured total skin thick-
ness (a surrogate marker of inflammation) using calipers. Interestingly, measurement of resting skin thickness 
showed CXCR2-deficient skin to be significantly thinner than WT skin (Fig. 1ai). This was not due to differences 
in dermal or epidermal thickness but to a marked reduction in the thickness of the sub-dermal adipose layer 
(Fig. 1aii). Given that the average difference in the thickness of the adipose layer was 75 μ m, and that 2 skin thick-
nesses were measured using the calipers, this difference in adiposity fully accounts for the resting differences in 
full skin thickness. Strikingly, and despite these resting differences, our data show that 48 hours after application 
of TPA to the lower dorsal skin of CXCR2-deficient mice, skin thickness was significantly increased compared 
to that in WT mice (Fig. 1aiii) indicative of increased inflammation. This was confirmed by haematoxylin and 
eosin staining. Importantly, this time point is delayed relative to the peak of neutrophil infiltration into the skin 
Figure 1. CXCR2-deficient mice display excessive cutaneous inflammatory responses. (a) The dorsal 
skin thickness of (i) resting or (iii) TPA treated (48 hours) wild type or CXCR2-deficient mice was measured 
using callipers and the adipose layer thickness (ii) of resting skin was digitally measured by microscopy on 
haematoxylin and eosin stained skin sections. (b) Dorsal skin from WT and CXCR2-deficient mice treated 
with TPA for (i) 24, (ii) 48 or (iii) 72 hours were sectioned and stained with haematoxylin and eosin and 
imaged using light microscopy. (c) Stained sections from skin harvested 48 hours after vehicle or TPA treatment 
were analysed to measure (i) epidermal and (ii) dermal thickness. (iii) dermal thickness is also shown from 
sections harvested over the post-TPA application period. a and ciii: Data are plotted as the mean (± SEM) of 
one experiment undertaken with 3–6 individual mice, representative of at least two independent experiments 
*P < 0.05, **P < 0.01, ***P < 0.001 as determined using Students T test. Ci and Cii: Data plotted as the mean 
(± SEM) of two experiments each undertaken in 4–7 mice *P < 0.05, **P < 0.01, ***P < 0.001 as determined 
using repeated measures ANOVA analysis with Tukey’s post hoc test.
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in this model (6–24 hrs)14. Gross imaging of the stained sections (Fig. 1b) demonstrated that whilst there were no 
apparent differences in thickness of WT and CXCR2-deficient skin at 24 or 72 hours, CXCR2-deficient skin was 
significantly thicker, than WT, 48 hours after TPA application (Fig. 1bii). This was quantified by systematically 
measuring epidermal and dermal thickness at 48 hours post-TPA application (Fig. 1c). These data demonstrated a 
similar modest TPA-dependent increase in epidermal thickness in both WT and CXCR2-deficient mice (Fig. 1ci) 
but a significantly greater increase in thickness of the dermal compartment in CXCR2-deficient, compared to 
WT, mice (Fig. 1cii) that was transient and gone by 72 hours (Fig. 1ciii).
TPA induces hyperproliferation of the epidermis and an influx of proliferating leukocytes. Ki67 staining 
of skin sections revealed increased epidermal proliferation in both WT and CXCR2-deficient mice at all-time 
points examined, with strongly increased proliferation of resident dermal cells at 48 hours post-TPA application 
selectively in the CXCR2-deficient mice (Supplementary Fig. 1a). This was quantified (Supplementary Fig. 1b) 
demonstrating that the increased numbers of Ki67+ ve dermal cells in CXCR2-deficient mice reached signif-
icance 48 hours post TPA application. This indicated an exaggerated dermal inflammatory response in the 
CXCR2-deficient mice which was also reflected in significantly increased size of skin draining lymph nodes at 
both 48 and 72 hours post TPA application (Supplementary Fig. 1c). Thus CXCR2 deficient mice display exagger-
ated cutaneous inflammatory responses.
Increased macrophage numbers are associated with exaggerated cutaneous inflammation in 
CXCR2-deficient mice. Notably, and as previously reported12, CXCR2-deficient mice display a modest but 
significant increase in the numbers of circulating neutrophils but no difference in the numbers resident in the 
bone marrow (Fig. 2ai and ii). No differences in the numbers of either bone marrow, or circulating cells with 
a monocyte-like morphology were detected in the CXCR2-deficient mice. Given the well-established role of 
CXCR2 in mediating neutrophil recruitment19, we examined neutrophil numbers in WT and CXCR2-deficient 
mouse skin following TPA application. Myeloperoxidase staining of sectioned skin (shown for 48 hour skin, 
Fig. 2bi) confirmed that there was significantly reduced neutrophil recruitment 24 hours and 48 hours after 
TPA application in CXCR2-deficient mice; whilst little, if any, positive staining was present in resting skin or 
72 hours after TPA application in WT or CXCR2-deficient mice (Fig. 2bii). Skin was then analysed for expression 
of MAC2, a macrophage marker20 (shown for 48 hours skin, Fig. 2ci). This revealed that MAC2+ ve cells are pres-
ent at significantly higher numbers in the CXCR2-deficient, compared to WT, skin at all time-points measured 
reaching a peak 48 hours after TPA application. Quantification of macrophage numbers indicated that the strong 
influx of macrophages was selectively observed in CXCR2-deficient skin whereas little change in staining was 
seen across these time points in the WT skin (Fig. 2cii). Finally, Astra blue (a mast cell stain21) analysis of the 
same sectioned skin samples revealed modestly increased mast cell numbers at 48 hours after TPA application 
in CXCR2-deficient mice, compared to WT mice (Fig. 2di). Again little, if any, increase in mast cell presence is 
Figure 2. Increased macrophage numbers are associated with exaggerated cutaneous inflammation 
in CXCR2-deficient mice. (a) Cytospin analysis was used to determine the neutrophil and monocyte-like 
cell content in (i) blood or (ii) bone marrow of WT and CXCR2-deficient mice. Skin sections from WT or 
CXCR2-deficient mice treated with TPA (harvested 48 hours after TPA application) were stained and analysed 
to measure the levels of (bi) myeloperoxidase+ ve cells, (ci) MAC2+ ve cells or (di) mast cells The kinetics of 
accumulation of these cell types are shown (0, 24, 48 and 72 hours after TPA application) in bii, cii and dii. Data 
are plotted as the mean (± SEM) of one experiment undertaken with 3–6 individual mice, representative of at 
least two independent experiments *P < 0.05, **P < 0.01 as determined using Students T test.
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observed across the time points analysed in the skin of WT mice (Fig. 2dii) and the higher basal levels of mast 
cells in resting CXCR2-deficient skins suggest that inflammation, overall, had little effect on mast cell numbers 
in either strain. Thus the excessive inflammatory phenotype in CXCR2-deficient mice correlates predominantly 
with the presence of macrophages (MAC2+ ) and the absence of neutrophils.
Inflamed CXCR2-deficient skin contains reduced levels of anti-inflammatory, and increased 
levels of pro-inflammatory, cytokines. We next used multiplexing approaches to measure the concen-
trations of pro and anti-inflammatory cytokines in the inflamed skins of WT and CXCR2-deficient mice. Skin 
samples were collected 24, 48 and 72 hours after TPA application and protein extracted by grinding in liquid nitro-
gen. Data from the multiplexing analysis revealed few significant differences between WT and CXCR2-deficient 
mouse skin however those that were detected are shown in Fig. 3a (24 hours), b (48 hours) and c (72 hours). 
These data indicate that TGF-β remained undetectable in skin from CXCR2-deficient mice, compared to WT, 
at 24 hours and levels remained suppressed at 48 hours. With IL-10, another anti-inflammatory cytokine, levels 
were not significantly different between WT and CXCR2-deficient mice at 24 hours (data not shown), however 
at 48 hours post-TPA application there were approximately 5-fold lower levels of IL-10 in CXCR2-deficient mice, 
compared to WT. 72 hours after TPA application both IL-10 and TGF-β levels were comparable in the wild type, 
and CXCR2-deficient, mouse skin and higher than at the earlier time points consistent with the ongoing reso-
lution of the inflammatory response. Conversely there was significantly more IL-1α present in the CXCR2 null 
mouse skin 24 hours post-TPA application although this was not maintained at 48 hours. Furthermore, and in 
contrast to WT mice, the CXCR2 ligand CXCL1 was readily detectable in the CXCR2-deficient mouse skin at 
both 24 and 48 hours. This is in agreement with previous findings suggesting that the chemokine ligand of a 
receptor is often detected at greater levels in its absence due to the lack of scavenging22,23. Overall, these findings 
suggest that reduced levels of anti-inflammatory cytokines, and increased levels of pro-inflammatory cytokines, 
may contribute to the excessive skin inflammation in CXCR2-deficient mice.
CXCR2-deficient mice display increased peritoneal inflammatory responses. In order to examine 
whether the inflammatory abnormalities in CXCR2-deficient mice were specific for cutaneous inflammation 
we next analysed the peritoneal inflammatory response to injection of zymosan. This response was measured 
at 48 hours post zymosan administration, after the peak of neutrophil recruitment in this model24, in order to 
act as a comparison to the observations from the cutaneous inflammatory model. Morphological analysis of the 
Figure 3. Inflamed CXCR2-deficient skin contains reduced levels of pro-resolution, and increased levels 
of pro-inflammatory, cytokines. Skin was harvested, and frozen, at either (a) 24 hours, (b) 48 hours or (c) 
72 hours following application of TPA to the skin of WT, or CXCR2-deficient, mice. The tissues were then 
ground in liquid nitrogen, re-suspended in PBS and analysed using a multiplex cytokine and chemokine 
array. Data are plotted as the mean (± SEM) of one experiment undertaken in 3 mice, representative of two 
independent experiments. *P < 0.05, **P < 0.01, ***P < 0.001 as determined using Students T test.
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peritoneal lavage following cytocentrifugation (Fig. 4a) revealed a significantly higher density of inflammatory 
cells in the peritoneal lavage in CXCR2-deficient, compared to WT, mice. Quantitative analysis of cells in these 
‘cytospins’ revealed a significant decrease in relative (Fig. 4b), and total (Fig. 4c), neutrophil numbers and, again, 
a significant increase in macrophage numbers in CXCR2-deficient, compared to WT, mouse peritoneal exudate 
(Fig. 4bi). More detailed analysis of specific cell morphology revealed, as expected, a significant reduction in the 
neutrophil infiltrate in the CXCR2-deficient mice (Fig. 4bii) along with a more modest reduction in the numbers 
of lymphocytes and eosinophils (Fig. 4biii and iv). Again, and in keeping with the data from the skin analysis, 
there was a highly significant increase in the number of macrophages present in the peritoneal lavage from the 
CXCR2-deficient mice (Fig. 4bv) which also displayed an enhanced proportion of mast cells (Fig. 4bvi). The same 
pattern between cells was observed when analysed as a relative percentage (Fig. 4b) and as a total number of cells 
per field of view (Fig. 4c). These differential counts were confirmed by flow cytometric analysis of the cellular 
content of the peritoneal lavage (specimen plots are shown in Supplementary Fig. 2a) which revealed an increase 
in overall cell number, and specifically of CD11b+ cells, in CXCR2-deficient mice (Supplementary Fig. 2b). 
The flow cytometric analysis also confirmed the reduction of Siglec-F+ eosinophils in the peritoneal lavage in 
CXCR2-deficient mice.
Further analysis (Fig. 5a) of the recruited excess macrophage population in CXCR2-deficient peritoneum 
revealed them to be predominantly CD11b+ F480+ Ly6Clo. These cells were significantly increased in number 
(Fig. 5b) in CXCR2-deficient inflamed peritoneum. In contrast Ly6C+ cells were relatively under-represented 
in CXCR2-deficient peritoneum. Interestingly, the CD11b+ F480+ Ly6Clo cells did not stain positive for CCR2 
expression (data not shown) which, together, suggests that they are likely to be derived from non-classical 
patrolling25, tissue repair, monocytes recruited to the inflammatory site. These findings are further strengthened 
by our data indicating that in the CXCR2-deficient peritoneum there is a significant increase in the number and 
Figure 4. CXCR2-deficient mice display increased peritoneal inflammatory response. Zymosan was intra-
peritoneally injected into mice and, 48 hours later, the mice were culled and the peritoneum flushed with PBS. 
(a) Cells were cytocentrifuged onto slides and subjected to differential analysis to identify component cell types 
(images shown at x40 magnification). Counts are expressed as a percentage of the total cells (b) or as the total 
number of cells per field of view (c). Cell counts were taken from at least 5 fields of view per sample and are 
plotted (for the indicated cell types) as the mean (± SEM) from groups containing at least 7 mice. These plots 
are representative of two independent experiments. *P < 0.05, **P < 0.01, ***P < 0.001 as determined using 
Students T test.
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proportion of CD11b+F480+CD206+macrophages (Fig. 5c and d). These macrophages have been tradition-
ally described as alternatively activated (M2) and further indicate a skew towards this population during the 
inflammatory response in CXCR2 null mice26. Thus CXCR2-deficient mice display an exaggerated inflammatory 
response to peritoneal administration of zymosan characterised by increased accumulation of macrophages with 
a ‘patrolling, tissue-repair’ phenotype.
Analysing the mechanistic basis for the phenotpe. Previously a number of studies has demonstrated 
an important role for apoptotic neutrophils in triggering anti-inflammatory responses through interaction with 
macrophages27,28. We therefore hypothesised that the exaggerated inflammation seen in CXCR2-deficient mice 
was a direct consequence of impaired neutrophil recruitment and associated reduction of macrophage-dependent 
anti-inflammatory cytokine release. Therefore, we directly tested the effects of apoptotic neutrophils on the 
macrophage ‘resolution’ phenotype. Intraperitoneal injection of thioglycollate was used to obtain neutro-
phils, which were then aged overnight to induce apoptosis. Inflammatory macrophages were also collected 
from thioglycolate-stimulated peritoneum of WT and CXCR2-deficient mice. Aged neutrophils, and purified 
macrophages, were then co-cultured for 24 hours and the cells separated and analysed for expression of the 
pro-resolving cytokine IL-10. ELISA analysis of media from these co-incubation experiments (Fig. 6a) confirmed 
that IL-10 expression was increased when macrophages were co-incubated with neutrophils and this was seen 
with both WT and CXCR2-deficient macrophages. Apoptotic neutrophils did not produce IL-10 when incubated 
alone (data not shown). These data confirm that CXCR2-deficient macrophages are fully capable of producing 
anti-inflammatory cytokines upon co-culture with apoptotic neutrophils and suggested that the reduced produc-
tion of IL-10 at inflamed sites in CXCR2-deficient mice may be a consequence of impaired neutrophil recruit-
ment and local interaction with macrophages.
To formally implicate impaired neutrophil recruitment in the phenotype that we have reported, we per-
formed additional experiments in which we used the anti-Ly6G antibody to deplete circulating neutrophils in 
WT mice prior to intraperitoneal administration of zymosan. As shown in Fig. 6b,c, this antibody brought about 
essentially complete depletion of the neutrophilic (Ly6G+ ) population. However, and in contrast to the data 
obtained using CXCR2-deficient mice, neutrophil depletion in WT mice in fact impaired recruitment of mac-
rophages to inflamed peritoneum. Together these data indicate that the basis for the phenotype observed appears 
to relate more to impaired recruitment of an alternative CXCR2+ ve leukocyte population than to reduced uptake 
Figure 5. CXCR2 null mice have increased levels of resident macrophages 48 hours after intra-peritoneal 
administration of zymosan. Zymosan was intra-peritoneally injected into mice, 48 hours later mice were 
culled and the peritoneum flushed with PBS and cells were then stained with antibodies against the indicated 
epitopes and analysed using flow cytometry, Cells were gated to select CD11b+F480+cells (as indicated in 
Supplementary information), these were then assessed for expression of Ly6C (A) and CD206 (C). Quantitative 
data from the flow cytometric assessments of Ly6C (B) and CD206 (D). Data are plotted as the mean (± SEM) 
from groups containing at least 7 mice. **P < 0.01, ***P < 0.001 as determined using Students T test.
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of apoptotic neutrophils by macrophages. We propose that this alternative CXCR2+ ve population may com-
prise myeloid derived suppressor cells29. In this regard, it is notable that monocytic MDSC (M-MDSCs30) are 
categorised as being Ly6CHi31,32 and that a Ly6CHi myeloid cell population in WT peritoneum is missing in 
CXCR2-deficient peritoneum (see Fig. 5a, upper gate).
Discussion
Given the ongoing attempts to target CXCR2 in inflammatory diseases and cancer8,15,18, it is of clear importance to 
fully understand and characterise the role of this receptor in the inflammatory response. Whilst our data re-iterate 
the importance of CXCR2 in supporting neutrophil recruitment to inflammatory sites, it also reveals a previ-
ously unanticipated role in controlling the magnitude of the macrophage-dependent inflammatory response. 
Specifically, our data show that cutaneous and peritoneal inflammation in CXCR2-deficient mice is characterised 
by a major reduction in the numbers of neutrophils present at the inflamed site and a corresponding increase in 
macrophage numbers. The speed with which macrophage numbers increase, especially in the zymosan model, 
suggests that this is not solely a consequence of increased local proliferation and is likely to be substantially 
dependent on de novo recruitment of these cells into the inflamed area This results in a transient exaggeration of 
the inflammatory response at both sites at time points after the peak of neutrophil recruitment14,21,24,33. Notably, 
in the skin, this is reflected in increased overall skin thickness which is accounted for entirely on the basis of 
increased dermal thickening. We did not observe epidermal thickening and interpret this as being a consequence 
of lack involvement of T cells in this response as it has previously been shown that T cells are important for induc-
ing epidermal thickening during TPA-induced inflammation21,34.
We proposed two hypotheses to explain our observations. Firstly, in inflammation, neutrophil recruitment 
precedes macrophage recruitment33,35, and interaction of apoptotic neutrophils with subsequently recruited mac-
rophages initiates resolution of the inflammatory response36. Accordingly the marked reduction of neutrophil 
recruitment in the CXCR2-deficient mice may contribute to the impaired induction of pro-resolution factors 
in recruited macrophages. However, experiments carried out using neutrophil-depleting antibodies suggested 
that the simple absence of neutrophil recruitment does not explain the phenotypes observed. Indeed, mice in 
which neutrophils were systemically depleted displayed reduced, and not exaggerated, macrophage recruitment. 
This has led us to conclude that the major role for CXCR2 in limiting inflammation relates to its expression 
on a non-neutrophil cell type. A potential candidate for such a cell is myeloid derived suppressor cells29 and 
their role in the phenotypes observed is further suggested by a specific reduction in a Ly6Chi monocytic cellular 
Figure 6. Analysis of neutrophil involvement in the exaggerated inflammatory response. (A) Macrophages 
from WT and CXCR2-deficient mice and WT aged-neutrophils purified from the peritoneum of thioglycollate-
injected mice were either incubated alone, or co-incubated for 24 hours. Culture media was analysed with 
an Elisa for IL-10 protein levels. Plotted as the mean (± SEM) of one experiment undertaken in triplicate. 
**P < 0.01; ***P < 0.001 as determined using repeated measures ANOVA analysis with Tukey’s post hoc test.  
(B) Either control or anti-Ly6G antibody (500 μ g) was injected into the mouse peritoneum (to deplete 
neutrophils) 24 hours before and after injection of zymosan (1 mg). 48 hours after zymosan injection mice were 
culled and the peritoneum flushed with PBS and the resulting lavage analysed using flow cytometry against the 
indicated epitopes. (C) Quantitative data from the flow cytometric assessments. Data are plotted as the mean  
(± SEM) from groups containing at least 4 mice. *P < 0.05, ***P < 0.001 as determined using Students T test.
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population31,32 along with the increased expression of pro-resolving cytokines such as TGFβ and IL-1037 in 
CXCR2-deficient mice.
Our data are in general agreement with previous studies demonstrating delayed wound healing in the 
CXCR2-deficient mice associated with reduced levels of TGF-β and enhanced monocyte recruitment at later time 
points38,39. However our data are in apparent contrast to a number of other studies demonstrating reduced acute 
inflammatory responses in CXCR2-deficient mice40. These are interpreted as being a consequence of altered neu-
trophil infiltration. However, these studies only looked at the earliest time points of the inflammatory response 
(typically 24 hours) and therefore missed the window of exaggerated inflammation identified in the present study. 
Specifically, our study mirrors that by Jamieson et al14 in demonstrating that neutrophil infiltration to the skin in 
response to a single TPA injection peaks after 24 hours, and that this is significantly reduced in CXCR2-deficient 
mice at all time points. However, in contrast to the data we describe here, the cellular content and overall mor-
phology of the skin was not monitored later than 24 hours after the single TPA application (acute phase), due to 
the focus of the study. Importantly the study by Jamieson and colleagues was performed using CXCR2-deficient 
mice on the same C57Bl/6 background as used in the current study thus arguing against strain-specific con-
tributions to the phenotype. Other studies have clearly demonstrated a beneficial effect of CXCR2-deficiency 
in mice during chronic models of inflammation14,40. However invariably these models involve continuous 
re-administration of inflammatory stimuli and thus are not immediately comparable with the current study that 
monitors later time points, after the peak of neutrophil recruitment, of the inflammatory response. Our experi-
mental models may more closely recapitulate routine acute inflammatory responses where the body is challenged 
by a one-off stimulus resulting in a rapidly resolving inflammatory response.
In summary this manuscript reports previously unanticipated pro-inflammatory consequences of 
CXCR2-deletion in acute inflammatory responses. Our data therefore contribute to our overall understanding of 
the involvement of this receptor in the orchestration of the inflammatory response.
Methods
Mice and models of inflammation. Animal experiments were performed using female age-matched mice 
in accordance with the animal care and welfare protocols approved by the Animal Welfare and Ethical Review 
Board at the University of Glasgow and carried out under the auspices of a UK Home Office Project Licence. WT 
C57Bl/6 and CXCR2-deficient mice were bred in ‘specific pathogen free’ conditions in the animal facility of the 
Beatson Institute for Cancer Research. Animal numbers reflect the number required to provide robust statistical 
evidence for significant effects. To generate sterile cutaneous inflammation, mice were shaved in the lower dorsal 
region before vehicle (acetone) or 12-O tetradecanoyl phorbol 13-acetate (TPA) was applied to the shaved skin as 
described21,34. Mice were culled 24, 48 or 72 hours after application and the desired tissues dissected and analysed 
as described below. Peritoneal inflammation was generated by injection of 200 μ l of 5 mg/ml zymosan (1 mg total) 
into the peritoneal cavity of each mouse, 48 hours later mice were culled and the peritoneal cellular contents 
analysed as described below.
Skin thickness analysis, staining and histology. Shaved lower dorsal skin was pinched together and 
the thickness measured using calipers. Skin samples were harvested following TPA application, fixed in forma-
lin, before being processed and embedded in paraffin wax. 5 μ m sections were cut from each sample transferred 
to SuperFrost microscope slides (Thermo Scientific) and baked at 65 °C for 30 minutes. Sections were then 
de-waxed with xylene before re-hydration and staining with haematoxylin and eosin counterstain, de-hydration 
and mounting with DPX (Leica). Blinded measurement of dermal and epidermal thickness from skin sections 
was undertaken using Zen software (Zeiss).
Inguinal lymph node analysis. Inguinal lymph nodes were removed, adhered onto SuperFrost micros-
copy slides (Thermo Scientific) and fixed overnight in formalin. Samples were then de-hydrated and incubated 
in xylene, before re-hydration and staining with Carmine solution, de-hydration and mounting with DPX. The 
lymph nodes were then imaged using bright-field microscopy on an EVOS microscope (Life Technologies) and 
the area occupied by the lymph nodes calculated from images using FIJI software41.
Analysis of skin inflammatory cell infiltrate by immunocytochemistry. Skin was processed as 
above. Following re-hydration sections were washed in PBS, blocked with 3% H2O2 (SigmaAldrich) and 20% 
goat serum (SigmaAldrich), sections were then stained with anti MAC-2 antibody (CedarlaneLaboratories) or 
isotype control rat IgG2a, κ (BD Biosciences) diluted 1/6000 in PBS containing 1% BSA (SigmaAldrich) and incu-
bated overnight at 4 °C. Sections were washed before addition of goat anti-rat IgG secondary antibody (Vector 
Laboratories) (30 minutes, room temperature), further washing with PBS, addition of Extravidin Peroxidase 
(Sigma) diluted 1/200 in PBS containing 1% BSA (30 minutes, room temperature) before washing and signal 
development with DAB reagent (Vector laboratories) and quenching with tap water. Stained sections were then 
washed, counter-stained with haematoxylin, de-hydrated and mounted with DPX.
Alternatively, following de-waxing and re-hydration of sections to 95% ethanol, they were then stained with 
Astra Blue dissolved in 95% ethanol (1 hour, room temperature), before washing in ethanol containing 5% hydro-
chloric acid, counterstain in 1% Safranin-O (1 minute, room temperature), further washing, dehydration and 
mounting in DPX.
Ki67 and myeloperoxidase analysis was undertaken at the Diagnostic Services Unit, School of Veterinary 
Medicine at the University of Glasgow using tissues processed as above.
Blinded cell counts were undertaken using blinded bright-field microscopy undertaken at the indicated mag-
nifications on a Zeiss Axiolimager M2 using Zeiss ZEN software.
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Skin protein content analysis. Skin samples from TPA experiments were ‘snap-frozen’ in liquid nitrogen, 
ground and re-suspended in PBS containing protease inhibitors (Life Technologies). Samples were then analysed 
using a mouse cytokine 20-plex kit (Life Technologies), used as directed in the kit and analysed with a Luminex 
100 machine (Bio-Rad).
Cytopsin analysis and Flow cytometry. Peritoneal cellular lavage, from mice injected with zymosan was 
spun and washed before re-suspension in FACS buffer (PBS + 0.1% BSA). Cells were then spun onto a microscopy 
slide using a cytocentrifuge before staining with 10% Giemsa solution and blinded cell morphology analysis. 
Alternatively, cell suspensions were stained with fixable viability dye (eBioscience) and antibodies against CD11b 
(eBioscience), F480 (eBioscience), Ly6C (Biolegend), CD206 (Biolegend) and SiglecF (BD Biosciences) (1/200 in 
FACS buffer). Cell suspensions were then washed in FACS buffer and run on a MACSQuant analyser (Miltenyi) 
and data processed using FlowJo software (Treestar Inc.).
Macrophage-Neutrophil co-culture. 1 ml of 3% Thioglycollate was injected into the peritoneum of mice 
and animals were culled either 18 hours (neutrophils) or 4 days (macrophages) later. For neutrophil purification 
the peritoneum was flushed with 5 ml of PBS containing 2 mM EDTA, cells were then separated and re-suspended 
in complete culture medium (DMEM with 10% FBS) in a tissue culture flask for 2 hours to remove adherent 
cells. Non-adherent cells (neutrophils) were removed and re-suspended to 5 × 106 cells/ml and aged overnight. 
Preparations of neutrophils were routinely of > 90% purity as assessed by FACS. Macrophages were isolated with 
the same approach: following incubation on a tissue culture flask non-adherent cells were removed to leave adher-
ent macrophages (100,000/well). These were then washed and incubated with aged neutrophils (200,000/well) for 
either 12 or 24 hours. At each stage cell samples were taken for cytospin analysis to confirm cellular purification. 
Culture medium was then removed and stored at − 80 °C before analysis undertaken using an Il-10 ELISA kit, as 
directed (Affymetrix, eBioscience).
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